NCT06528691 2026-02-17Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS TumorsSt. Jude Children's Research HospitalPhase 2 Recruiting52 enrolled